PLEASANTON, Calif. - 10x Genomics, Inc. (NASDAQ: NASDAQ:TXG), a company specializing in single cell and spatial biology, has launched Visium HD Spatial Gene Expression, a new product designed to enable researchers to conduct whole transcriptome analysis from formalin-fixed paraffin-embedded (FFPE) tissue sections at a resolution comparable to that of single cells.
Announced today, Visium HD is characterized by its ability to map gene expression with high precision, which is expected to enhance the study of complex biological tissues. The product combines spatial gene expression data with histological images, allowing a more detailed examination of FFPE tissue samples.
According to Michael Schnall-Levin, Founding Scientist and Chief Technology Officer at 10x Genomics, "Visium HD is a game-changer for spatial discovery research." He expressed confidence that the product, which he described as the most requested in the company's history, would significantly impact scientific research.
Visium HD boasts several features, including a next-generation slide architecture that provides transcript data in 2 x 2 µm barcoded squares, enabling the resolution of fine anatomical structures and cell types at a single cell-scale. It also offers compatibility with human or mouse FFPE samples and integrates with analytical tools such as Space Ranger and Loupe Browser for data exploration.
To introduce Visium HD to the scientific community, 10x Genomics will host a webinar on April 2, 2024. The company's products are widely used in various fields, including oncology, immunology, and neuroscience, contributing to advancements in the understanding of health and disease.
The launch of Visium HD is based on a press release statement from 10x Genomics and reflects the company's ongoing efforts to provide innovative solutions for the analysis of biological systems.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.